Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024.

Autor: Bryce AH; Department of Medical Oncology and Therapeutics Research, City of Hope Phoenix, Phoenix, Arizona, USA., Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Hussain MH; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, Illinois, USA., Sartor O; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Shore N; Carolina Urologic Research Center, Myrtle Beach, South Carolina, USA., Antonarakis ES; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, USA., Carducci MA; Hopkins Kimmel Cancer Center, Baltimore, Maryland, USA., Dorff TB; City of Hope Comprehensive Cancer Center, Duarte, California, USA., Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Gleave M; Urological Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, British Columbia, Canada., Gomella LG; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Higano C; Madrona Oncology, Seattle, Washington, USA., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA., Iagaru A; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California, USA., Morgans AK; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Morris DS; Urology Associates PC, Nashville, Tennessee, USA., Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Petrylak DP; Yale New Haven Health, New Haven, Connecticut, USA., Reiter RE; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA., Rettig MB; Division of Hematology-Oncology, Department of Medicine, VA Greater Los Angeles, Los Angeles, California, USA.; Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA.; Department of Urology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA., Ryan CJ; Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Sellinger SB; Advanced Urology Institute, Tallahassee, Florida, USA., Spratt DE; University Hospitals Seidman Cancer Center, Cleveland, Ohio, USA., Srinivas S; Division of Medical Oncology, Stanford University Medical Center, Stanford, California, USA., Tagawa ST; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA., Taplin ME; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Yu EY; Division of Hematology and Oncology, Department of Medicine, University of Washington and Fred Hutchinson Cancer Center, Seattle, Washington, USA., Zhang T; Division of Hematology and Oncology, Department of Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA., McKay RR; Department of Urology, University of California San Diego, La Jolla, California, USA.; Department of Medicine, University of California San Diego, La Jolla, California, USA., Koo PJ; Banner MD Anderson Cancer Center, Phoenix, Arizona, USA., Crawford ED; Department of Urology, University of California San Diego, La Jolla, California, USA.

Publikováno v: Cancer [Cancer] 2024 Dec 01. Date of Electronic Publication: 2024 Dec 01.